← Back to Clinical Trials
Recruiting NCT06575842

NCT06575842 Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06575842
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Type 1 Diabetes
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2024-08-21
Primary Completion 2027-12-01

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 26 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2024-08-21 with a primary completion date of 2027-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.

Eligibility Criteria

Inclusion Criteria: 1. Participants will be 2 to 26 years of age at the time of enrollment. 2. Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period. 3. Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account. Exclusion Criteria: 1. Pregnancy. 2. Currently using hydroxyurea. 3. A condition that the investigator determines would prevent the patient from participation.

Contact & Investigator

Central Contact

Erin Cobry, MD

✉ Erin.Cobry@cuanschutz.edu

📞 3037242323

Frequently Asked Questions

Who can join the NCT06575842 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 26 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06575842 currently recruiting?

Yes, NCT06575842 is actively recruiting participants. Contact the research team at Erin.Cobry@cuanschutz.edu for enrollment information.

Where is the NCT06575842 trial being conducted?

This trial is being conducted at Aurora, United States.

Who is sponsoring the NCT06575842 clinical trial?

NCT06575842 is sponsored by University of Colorado, Denver. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology